Barclays PLC Bio Rad Laboratories, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Barclays PLC holds 41,976 shares of BIO stock, worth $13.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,976

Previous 41,976 -0.0%

Holding current value

$13.9 Million

Previous $14 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$263.97 - $344.64 $1.43 Million - $1.86 Million	-5,406 Reduced 11.41%	41,976 $14 Million
Q2 2024 Aug 14, 2024	BUY	$268.26 - $339.48 $2.02 Million - $2.56 Million	7,528 Added 18.89%	47,382 $12.9 Million
Q1 2024 May 15, 2024	SELL	$304.11 - $351.99 $6.72 Million - $7.78 Million	-22,098 Reduced 35.67%	39,854 $13.8 Million
Q4 2023 Feb 15, 2024	BUY	$269.37 - $365.04 $4.51 Million - $6.11 Million	16,747 Added 37.05%	61,952 $20 Million
Q3 2023 Nov 07, 2023	BUY	$350.25 - $422.63 $436,061 - $526,174	1,245 Added 2.83%	45,205 $16.2 Million
Q2 2023 Aug 03, 2023	BUY	$359.49 - $486.4 $7.39 Million - $10 Million	20,554 Added 87.82%	43,960 $16.7 Million
Q1 2023 May 04, 2023	SELL	$418.69 - $503.0 $18 Million - $21.6 Million	-42,996 Reduced 64.75%	23,406 $11.2 Million
Q4 2022 Feb 13, 2023	BUY	$351.71 - $456.01 $4.32 Million - $5.61 Million	12,293 Added 22.72%	66,402 $27.9 Million
Q3 2022 Nov 03, 2022	BUY	$412.59 - $563.26 $12.7 Million - $17.4 Million	30,863 Added 132.77%	54,109 $22.6 Million
Q2 2022 Aug 12, 2022	SELL	$463.67 - $597.16 $2.15 Million - $2.76 Million	-4,628 Reduced 16.6%	23,246 $11.5 Million
Q1 2022 May 16, 2022	SELL	$524.57 - $735.42 $4.67 Million - $6.55 Million	-8,911 Reduced 24.22%	27,874 $15.7 Million
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $6.29 Million - $7.06 Million	-8,878 Reduced 19.44%	36,785 $27.8 Million
Q3 2021 Nov 09, 2021	BUY	$657.71 - $825.77 $8.45 Million - $10.6 Million	12,847 Added 39.15%	45,663 $34.1 Million
Q2 2021 Aug 13, 2021	BUY	$576.64 - $649.04 $293,509 - $330,361	509 Added 1.58%	32,816 $21.1 Million
Q1 2021 May 13, 2021	BUY	$547.01 - $662.35 $6.23 Million - $7.55 Million	11,397 Added 54.51%	32,307 $18.5 Million
Q4 2020 Feb 11, 2021	SELL	$510.68 - $643.45 $20,427 - $25,738	-40 Reduced 0.19%	20,910 $12.2 Million
Q3 2020 Nov 12, 2020	BUY	$454.43 - $535.6 $190,406 - $224,416	419 Added 2.04%	20,950 $10.8 Million
Q2 2020 Aug 12, 2020	SELL	$334.87 - $493.06 $2.13 Million - $3.13 Million	-6,354 Reduced 23.63%	20,531 $9.27 Million
Q1 2020 May 13, 2020	BUY	$320.01 - $409.07 $112,963 - $144,401	353 Added 1.33%	26,885 $9.43 Million
Q4 2019 Feb 10, 2020	SELL	$319.73 - $374.2 $2.62 Million - $3.07 Million	-8,193 Reduced 23.59%	26,532 $9.82 Million
Q3 2019 Nov 14, 2019	BUY	$304.55 - $345.24 $1.07 Million - $1.22 Million	3,528 Added 11.31%	34,725 $11.6 Million
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $7.61 Million - $8.29 Million	26,508 Added 565.32%	31,197 $9.75 Million
Q1 2019 May 15, 2019	SELL	$224.3 - $317.41 $9.42 Million - $13.3 Million	-42,017 Reduced 89.96%	4,689 $1.43 Million
Q4 2018 Feb 14, 2019	BUY	$220.1 - $309.0 $8.73 Million - $12.3 Million	39,653 Added 562.21%	46,706 $10.8 Million
Q3 2018 Nov 14, 2018	BUY	$289.28 - $326.15 $805,355 - $908,001	2,784 Added 65.21%	7,053 $2.21 Million
Q2 2018 Aug 14, 2018	SELL	$244.1 - $303.88 $296,825 - $369,518	-1,216 Reduced 22.17%	4,269 $1.23 Million
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $480,106 - $562,473	-2,052 Reduced 27.23%	5,485 $1.37 Million
Q4 2017 Feb 14, 2018	BUY	$216.94 - $271.3 $1.34 Million - $1.67 Million	6,157 Added 446.16%	7,537 $1.8 Million
Q3 2017 Nov 14, 2017	BUY	$212.27 - $242.28 $292,932 - $334,346	1,380	1,380 $307,000

Others Institutions Holding BIO

# of Institutions

456

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.14B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account